ShanZhen
善诊
ShanZhen (善诊) is a healthcare company in BlueRun Ventures' portfolio, which has invested in over 200 startups including it . The firm was recognized in the 2024 Future Healthcare 100 list, placing on the China Healthcare and Health Innovation Services TOP100 . elsewhere's corpus does not contain additional detail on its founding, business model, or leadership.
AI-generated — may contain errors, please verify.
Coverage
Early Summer, Time to Surf to Your Heart's Content! | BlueRun Ventures Bi-Monthly Report
The thrill of surfing freely under a blazing sun.
BlueRun Ventures Portfolio Companies Named to 2024 Future Healthcare 100 List
Continuously searching for next-generation biotech companies that align with industry logic
Surging Waves, Endless Ascent | June Report
Go all in, or don't join at all.
Multiple BlueRun Ventures portfolio companies named to 2023 Future Healthcare 100 list
Standing by founders from 0 to 1 to redefine the future.
BlueRun Ventures in September | A River Grows by Welcoming Every Stream
Every harvest is a mixture of patience and time.
Galloping Through August | Living Up to the Summer, Chasing What We Love
Every step counts.
Strategy First, or Organization First? | BlueRun Ventures Portfolio Event on Organizational Capacity
Forging a "Muscular" Organization
BlueRun Ventures and Portfolio Companies Win Nearly 60 Awards from 36Kr, ChinaVenture, Rongzhong, TMTpost, VBData, and More | H1 Highlights
Deep commitment to early-stage investing, with a belief in technology as a driver of transformation.
